The Effects of Mental Practice Combined With Proprioceptive Neuromuscular Facilitation on Muscle Strength of Upper Limb and Hand Grip

NCT ID: NCT03767413

Last Updated: 2019-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-16

Study Completion Date

2019-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Influence of mental practice and proprioceptive neuromuscular facilitation on muscle strength of upper limb and hand grip will be measured in 30 to 50 healthy students with right dominant hand, Their age will be ranged from 18 to 26 years old. Subjects will randomly assigned to either proprioceptive neuromuscular facilitation (PNF) group or proprioceptive neuromuscular facilitation with mental practice (PNFMP) group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PNF group: 15 - 25 individuals, these subjects will receive only PNF training. PNFMP: 15 individuals, these subjects will receive PNF training with MP. Training program will be conducted for every group for 5 weeks with 3 sessions x 30 min per week. Electromyography (EMG) device will be used to measure the electrical activity of muscles using surface electrodes. Hydraulic hand dynamometer will be used to measure hand grip strength.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motor Activity Physical Activity Neuromuscu

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There are two group of subjects: PNF group will receive only PNF training PNFMP group: will receive PNF training and mental pracice technique
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PNF group

It will be consisted of 15 -25 healthy subjects receiving only proprioceptive nueromuscular facilitation training for 5 weeks with 17 days follow up after completion of program.

Group Type ACTIVE_COMPARATOR

PNF

Intervention Type PROCEDURE

proprioceptive neuromuscular facilitation training

PNFMP

It will be consisted of 15 -25 healthy subjects receiving proprioceptive nueromuscular facilitation training and mental practice technique for 5 weeks with 17 days follow up after completion of program.

Group Type EXPERIMENTAL

PNFMP

Intervention Type PROCEDURE

proprioceptive neuromuscular facilitation training and mental practice technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PNF

proprioceptive neuromuscular facilitation training

Intervention Type PROCEDURE

PNFMP

proprioceptive neuromuscular facilitation training and mental practice technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The participant will be right-handed.
2. Previously untrained subjects.
3. Absence of a prior injury of the hand or arm

Exclusion Criteria

1. History of a neurological disease.
2. History of musculoskeletal injury of upper limb.
3. Unstable medical condition
Minimum Eligible Age

18 Years

Maximum Eligible Age

26 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Jazan

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wafaa Mahmoud Amin

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jazan University

Riyadh, Jazan Region, Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8810025277

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.